Elanco Animal Health Inc (NYSE: ELAN) on Tuesday, soared 3.64% from the previous trading day, before settling in for the closing price of $21.7. Within the past 52 weeks, ELAN’s price has moved between $8.02 and $23.70.
A company in the Healthcare sector has jumped its sales by 29.95% annually for the last half of the decade. The company achieved an average annual earnings per share of 2.53%. With a float of $492.27 million, this company’s outstanding shares have now reached $496.83 million.
Elanco Animal Health Inc (ELAN) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Elanco Animal Health Inc is 0.92%, while institutional ownership is 115.69%. The most recent insider transaction that took place on Dec 12 ’25, was worth 213,000. In this transaction Director of this company bought 10,000 shares at a rate of $21.30, taking the stock ownership to the 131,773 shares. Before that another transaction happened on Dec 11 ’25, when Company’s insider bought 4,500 for $21.33, making the entire transaction worth $95,985. This insider now owns 123,082 shares in total.
Elanco Animal Health Inc (ELAN) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.14 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.15) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.16% during the next five years compared to 29.95% growth over the previous five years of trading.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Elanco Animal Health Inc (ELAN) is currently performing well based on its current performance indicators. A quick ratio of 1.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43. Likewise, its price to free cash flow for the trailing twelve months is 30.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.07, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 1.03 in one year’s time.
Technical Analysis of Elanco Animal Health Inc (ELAN)
Let’s dig in a bit further. During the last 5-days, its volume was 5.8 million. That was inferior than the volume of 5.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.11%.
During the past 100 days, Elanco Animal Health Inc’s (ELAN) raw stochastic average was set at 88.26%, which indicates a significant increase from 63.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.64 in the past 14 days, which was higher than the 0.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.73, while its 200-day Moving Average is $15.89. However, in the short run, Elanco Animal Health Inc’s stock first resistance to watch stands at $22.78. Second resistance stands at $23.06. The third major resistance level sits at $23.57. If the price goes on to break the first support level at $21.99, it is likely to go to the next support level at $21.48. The third support level lies at $21.20 if the price breaches the second support level.
Elanco Animal Health Inc (NYSE: ELAN) Key Stats
Market capitalization of the company is 11.17 billion based on 496,863K outstanding shares. Right now, sales total 4,439 M and income totals 338,000 K. The company made 1,137 M in profit during its latest quarter, and -34,000 K in sales during its previous quarter.
